STRATASYS LTD. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD from Q4 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Stratasys Ltd. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and growth rate from Q4 2016 to Q1 2024.
  • Stratasys Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending March 31, 2024 was $91.4M, a 56.4% decline year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $91.4M -$118M -56.4% Mar 31, 2024 6-K 2024-05-30
Q4 2023 $82.9M -$67.8M -45% Dec 31, 2023 6-K 2024-05-30
Q3 2023 $105M -$46M -30.5% Sep 30, 2023 6-K 2023-11-16
Q2 2023 $145M -$115M -44.2% Jun 30, 2023 6-K 2023-08-09
Q1 2023 $209M -$84.4M -28.7% Mar 31, 2023 6-K 2024-05-30
Q4 2022 $151M -$92.6M -38.1% Dec 31, 2022 6-K 2024-05-30
Q3 2022 $151M -$182M -54.7% Sep 30, 2022 6-K 2023-11-16
Q2 2022 $259M -$84.6M -24.6% Jun 30, 2022 6-K 2023-08-09
Q1 2022 $294M -$128M -30.3% Mar 31, 2022 6-K 2023-05-16
Q4 2021 $243M -$28.9M -10.6% Dec 31, 2021 20-F 2024-03-11
Q3 2021 $333M +$80M +31.6% Sep 30, 2021 6-K 2022-11-10
Q2 2021 $344M +$59M +20.7% Jun 30, 2021 6-K 2022-08-03
Q1 2021 $422M +$124M +41.8% Mar 31, 2021 6-K 2022-05-17
Q4 2020 $272M -$21.4M -7.28% Dec 31, 2020 20-F 2024-03-11
Q3 2020 $253M -$94.2M -27.1% Sep 30, 2020 6-K 2021-11-04
Q2 2020 $285M -$81.8M -22.3% Jun 30, 2020 6-K 2021-08-05
Q1 2020 $297M -$71.1M -19.3% Mar 31, 2020 6-K/A 2021-05-05
Q4 2019 $294M -$100M -25.4% Dec 31, 2019 20-F 2023-03-03
Q3 2019 $347M -$2.27M -0.65% Sep 30, 2019 6-K 2020-11-12
Q2 2019 $367M +$19.4M +5.58% Jun 30, 2019 6-K 2020-08-05
Q1 2019 $368M +$21.3M +6.13% Mar 31, 2019 6-K 2020-05-14
Q4 2018 $394M +$64.4M +19.5% Dec 31, 2018 20-F 2022-02-24
Q3 2018 $349M +$46.4M +15.3% Sep 30, 2018 6-K 2019-11-13
Q2 2018 $347M +$41.6M +13.6% Jun 30, 2018 6-K 2019-07-31
Q1 2018 $347M +$49.3M +16.5% Mar 31, 2018 6-K 2019-05-02
Q4 2017 $329M +$48.7M +17.4% Dec 31, 2017 20-F 2021-03-01
Q3 2017 $303M Sep 30, 2017 6-K 2018-11-01
Q2 2017 $306M Jun 30, 2017 6-K 2018-08-01
Q1 2017 $298M Mar 31, 2017 6-K 2018-05-02
Q4 2016 $281M Dec 31, 2016 20-F 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.